Stocklytics Platform
Asset logo for symbol VCEL
Vericel
VCEL76
$56.50arrow_drop_up2.78%$1.52
High Growth
Asset logo for symbol VCEL
VCEL76

$56.50

arrow_drop_up2.78%

Performance History

Chart placeholder
Key Stats
Open$54.40
Prev. Close$54.95
EPS0.08
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range53.92
57.25
52 Week Range30.18
63.00
Ratios
EPS0.08

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Vericel (VCEL)

Vericel Corp (VCEL) is a biopharmaceutical company specializing in the development and commercialization of cell therapies. The company's flagship product is MACI, an autologous cellularized scaffold used for the repair of symptomatic, full-thickness cartilage defects of the knee in adult patients. Vericel also offers Epicel, a permanent skin replacement for patients with deep dermal or full-thickness burns. Both products have been approved by the FDA and have shown significant clinical benefits.
VCEL stock has seen a steady increase in price over the years, reflecting the growing demand for regenerative medicine solutions. The company's market cap currently stands at $X billion, indicating strong investor confidence. The PEG ratio for Vericel Corp is X, suggesting a favorable valuation compared to its earnings growth rate. This indicates that the stock may be undervalued and could provide a potential investment opportunity.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Dominick C. Colangelo Esq.
Headquarters
Cambridge
Employees
305
Exchange
NASDAQ
add Vericel to watchlist

Keep an eye on Vericel

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Vericel's (VCEL) price per share?

The current price per share for Vericel (VCEL) is $56.5. The stock has seen a price change of $1.53 recently, indicating a 2.78% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Vericel (VCEL)?

For Vericel (VCEL), the 52-week high is $63, which is 11.5% from the current price. The 52-week low is $30.18, the current price is 87.21% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Vericel (VCEL) a growth stock?

Vericel (VCEL) has shown an average price growth of -4.38% over the past three years. It has received a score of 75 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vericel as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Vericel (VCEL) stock price performance year to date (YTD)?

As of the latest data, Vericel (VCEL) has a year-to-date price change of 61.98%. Over the past month, the stock has experienced a price change of -0.37%. Over the last three months, the change has been 21.85%. Over the past six months, the figure is 25.56%. Looking at a longer horizon, the five-year price change stands at 217.06%.
help

Is Vericel (VCEL) a profitable company?

Vericel (VCEL) has a net income of -$3.18M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.64% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.26% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $197.52M, with a revenue growth rate of 20.17%, providing insight into the company's sales performance and growth. The gross profit is $135.58M. Operating income is noted at -$6.46M. Furthermore, the EBITDA is $2.86M.
help

What is the market capitalization of Vericel (VCEL)?

Vericel (VCEL) has a market capitalization of $2.79B. The average daily trading volume is 56.12, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level